The epidemiology of cholangiocarcinoma.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Seminars in liver disease (Print)

• Publication date

  2004-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/S-2004-828889PMID 15192785
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?

  2004cited by this paper
• Cancer Statistics, 2003

  2003cited by this paper
• Cholangiocarcinoma: Recent progress. Part 1: Epidemiology and etiology

  2002cited by this paper
• Increasing incidence of cholangiocarcinoma in Crete 1992-2000.

  2002cited by this paper
• Liver fluke‐associated cholangiocarcinoma

  2002cited by this paper
• Changing international trends in mortality rates for liver, biliary and pancreatic tumours.

  2002cited by this paper
• Parasitic Infections and Hepatic Neoplasia

  2002cited by this paper
• Worldwide trends in mortality from biliary tract malignancies

  2002cited by this paper
• Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998

  2001cited by this paper
• Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case–control study in Italy

  2001cited by this paper
• Carcinoma arising in choledochocele.

  2001cited by this paper
• Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States

  2001cited by this paper
• Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus–related cirrhosis

  2000cited by this paper
• Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case‐control study

  2000cited by this paper
• Peripheral cholangiocarcinoma (cholangiocellular carcinoma): Clinical features, diagnosis and treatment

  1999cited by this paper
• Biliary tract cancers.

  1999cited by this paper
• Detection of hepatitis C virus RNA sequences in hepatic portal cholangiocarcinoma tissue by reverse transcription polymerase chain reaction.

  1998cited by this paper
• Risk of liver and other types of cancer in patients with cirrhosis: A nationwide cohort study in Denmark

  1998cited by this paper
• Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: A case‐control study

  1998cited by this paper
• Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A population-based study.

  1997cited by this paper
• Hepatitis C virus genotypes in patients with hepatocellular carcinoma and cholangiocarcinoma in Thailand.

  1996cited by this paper
• Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.

  1996cited by this paper
• Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea.

  1996cited by this paper
• Liver, gallbladder, extrahepatic bile ducts, and pancreas

  1995cited by this paper
• Choledochal Cyst Disease A Changing Pattern of Presentation

  1994cited by this paper
• Recent Advances in the Management of Cholangiocarcinomas

  1994cited by this paper
• Surgical management and long-term follow-up of patients with choledochal cysts.

  1993cited by this paper
• Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention.

  1993cited by this paper
• Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma

  1991cited by this paper
• Liver cancer in Thailand. I. A case‐control study of cholangiocarcinoma

  1991cited by this paper
• Cholangiocarcinoma complicating primary sclerosing cholangitis.

  1991cited by this paper
• Level ofOpisthorchis infestation and carcinogen dose-dependence of cholangiocarcinoma induction in Syrian golden hamsters

  1987cited by this paper
• Primary sclerosing cholangitis: a long-term follow-up study.

  1987cited by this paper
• International variations in epidemiology of cancers of the extrahepatic biliary tract.

  1985cited by this paper
• Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria--an epidemiological investigation.

  1984cited by this paper
• Comparison of intravenous radionuclide cholescintigraphy and endoscopic retrograde cholangiography in the diagnosis of intrahepatic gall-stones.

  1981cited by this paper
• Bacteria and gallstones

  1981cited by this paper
• Clinicopathologic features of the syndrome of primary sclerosing cholangitis.

  1980cited by this paper
• Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology.

  1980cited by this paper
• Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters.

  1978cited by this paper
• Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma. A study of 57 autopsy‐proven cases

  1977cited by this paper

• Immunotherapy checkpoint inhibitor-combination therapy versus chemotherapy alone among Chinese population in cholangiocarcinoma treatment: a systematic review and meta-analysis

  2026cites this paper
• Exploring the Role of Extracellular Vesicles in Pancreatic and Hepatobiliary Cancers: Advances Through Artificial Intelligence

  2026cites this paper
• Transcriptome insights into newcastle disease virus-mediated eradication of cholangiocarcinoma cells

  2025cites this paper
• Clinicopathological significance and prognostic impact of perineural invasion in intrahepatic cholangiocarcinoma: a single-center, retrospective study.

  2025cites this paper
• Molecular mechanisms and genetic features of cholangiocarcinoma: implications for targeted therapeutic strategies

  2025influential citation
• It’s all about FAPI – aktuelle Anwendungen der FAPI-PET

  2025cites this paper
• PufA drives cholangiocarcinoma progression via NFκB signaling activation: a novel therapeutic target

  2025cites this paper
• Choledocholithiasis as a risk factor for cholangiocarcinoma: a nationwide retrospective cohort study

  2025cites this paper
• Forty-five-year trends in intra- and extrahepatic cholangiocarcinoma: sex- and race-based insights

  2025cites this paper
• Innovative Construction and Application of Bile Duct Organoids: Unraveling the Complexity of Bile Duct Diseases and Potential Therapeutic Strategies.

  2025cites this paper
• Digestive cancers: mechanisms, therapeutics and management

  2025cites this paper
• Recurrence-Free Survival as a Surrogate for Overall Survival Among Patients with Intrahepatic Cholangiocarcinoma Following Upfront Surgery: An International Multi-institutional Analysis

  2025cites this paper
• The Value of FAPI PET/CT in Cholangiocarcinoma and Pancreatic Cancer: An Update.

  2025cites this paper
• Racial and Ethnic Disparities in Survival Among Patients with Cholangiocarcinoma in the United States: A Systematic Review and Meta-Analysis.

  2025cites this paper
• Outcomes and Role of Lymphadenectomy in Hypervascular Intrahepatic Cholangiocarcinoma Based on CT-Vascularity.

  2025cites this paper
• The Impact of 18F-FDG PET/CT and Related Parameters on Staging, Disease Management and Prognosis in Patients with Cholangiocarcinoma

  2025cites this paper
• Emerging HER2 Targeting Immunotherapy for Cholangiocarcinoma

  2025influential citation
• Serum Transforming Growth Factor Beta 1 as a Diagnostic Marker for Cholangiocarcinoma

  2025cites this paper
• Impact of Race on Admission, Clinical Outcomes, and Disposition in Cholangiocarcinoma: Insights from the National Inpatient Database

  2025cites this paper
• Efficacy of Combined Dabrafenib and Trametinib Therapy in BRAFV600E Mutant Intrahepatic Cholangiocarcinoma with a Neurofibromatosis Type 2 Mutation

  2025cites this paper
• "Biological R2" resection for intrahepatic cholangiocarcinoma: identification of patients at risk for poor oncologic outcomes after curative-intent resection.

  2025cites this paper
• Prognostic Significance of Lymphocyte-to-Monocyte Ratio in Patients With Unresectable Biliary Tract Cancer Undergoing Systemic Chemotherapy

  2025cites this paper
• Hepatic Arterial Infusion Pump Chemotherapy in Patients With Unresectable Intrahepatic Cholangiocarcinoma-PUMP-2 Trial.

  2025cites this paper
• Integrating Etiological Insights With Machine Learning for Precision Diagnosis of Obstructive Jaundice: Findings From a High-Volume Center

  2025cites this paper
• DNA damage response and repair gene mutations predict clinical outcomes in biliary tract cancer

  2025cites this paper
• A Case of Biliary Intraepithelial Neoplasm in a Young Man Diagnosed by Laparoscopic Hepatectomy to Treat Recurrent Intrahepatic Lithiasis and Cholangitis

  2025cites this paper
• Diagnosis and Management of Cholangiocarcinoma (CCA)

  2025cites this paper
• Higher expression of high-mobility group box 1 in cholangiocarcinoma and association with cell growth, in vitro migration and invasion, and chemo-drug sensitivity

  2025cites this paper
• Endobiliary Radiofrequency Ablation for Hepato-Biliary Diseases: A Narrative Review

  2025cites this paper
• Role of Coagulation Irregularities in Cholangiocarcinoma: A review

  2025cites this paper
• Outcomes of Living-Donor Liver Transplantation for Cholangiocarcinoma Versus Hepatocellular Carcinoma in the United States

  2025cites this paper
• Liver Transplant for Intrahepatic Cholangiocarcinoma: Current Evidence and Clinical Practice Recommendations.

  2025cites this paper
• Psychological adaptation and prevention behaviors during the COVID-19 pandemic: a moderated mediation model

  2025cites this paper
• Mapping the landscape of biliary tract cancer in Europe: challenges and controversies

  2025cites this paper
• Burden and risk factors of suspected cholangiocarcinoma in high Opisthorchis viverrini endemic rural communities in southern Lao PDR

  2024cites this paper
• Optimizing outcomes and personalizing care with targeted agents in advanced cholangiocarcinoma.

  2024cites this paper
• Polysaccharide extract of Spirulina sp. increases effector immune-cell killing activities against cholangiocarcinoma

  2024cites this paper
• Evaluating the prognostic impact of inflammatory markers on treatment outcomes in patients with intrahepatic cholangiocarcinoma undergoing radioembolization

  2024cites this paper
• Cholangiocarcinoma: A Comprehensive Review and Update Guideline

  2024influential citation
• Extrahepatic biliary neuroendocrine tumors: A national cancer database analysis

  2024cites this paper
• Cholangiocarcinoma With Liver Metastasis in Squamous Cell Carcinoma Type: A Case Report

  2024cites this paper
• Unveiling novel serum biomarkers in intrahepatic cholangiocarcinoma: a pilot proteomic exploration

  2024cites this paper
• Cholangiocarcinoma imaging: from diagnosis to response assessment

  2024cites this paper
• Nodal recurrence mapping and clinical target volumes after resection of intrahepatic cholangiocarcinoma or combined hepatocellular-cholangiocarcinoma

  2024cites this paper
• Prognostic risk factors in 113 patients undergoing cephalic duodenopancreatectomy for distal cholangiocarcinoma

  2024cites this paper
• Spatio-Temporal Analysis of Cholangiocarcinoma in a High Prevalence Area of Northeastern Thailand: A 10-Year Large Scale Screening Program

  2024cites this paper
• The clinicopathological significance and prognostic impact of 14-3-3σ/stratifin expression on patients with surgically resectable intrahepatic cholangiocarcinoma.

  2024cites this paper
• Insight Into the Role of Alkaloids in the Different Signalling Pathways of Cholangiocarcinoma

  2024cites this paper
• Prognostic Factors in Intrahepatic Cholangiocarcinoma - A Systematic Review.

  2024cites this paper
• Role of long non‐coding RNAs in cholangiocarcinoma: A systematic review and meta‐analysis

  2024influential citation
• Regulation of lipid metabolism by APOE4 in intrahepatic cholangiocarcinoma via the enhancement of ABCA1 membrane expression

  2024cites this paper
• Hepatic arterial infusion chemotherapy combined with toripalimab and surufatinib for the treatment of advanced intrahepatic cholangiocarcinoma

  2024cites this paper
• CHẤT ỨC CHẾ AURORA KINASE TAK-901 KÌM HÃM SỰ TĂNG SINH TẾ BÀO UNG THƯ ĐƯỜNG MẬT

  2024influential citation
• Tubulocystic Carcinoma of Bile Ducts

  2024cites this paper
• Novel Adiponectin Receptor Agonist Inhibits Cholangiocarcinoma via Adenosine Monophosphate-activated Protein Kinase.

  2024cites this paper
• HBV infection effects prognosis and activates the immune response in intrahepatic cholangiocarcinoma

  2024cites this paper
• Sonographic Predictors for Developing Cholangiocarcinoma: A Cohort Study from an Endemic Area

  2024cites this paper
• Standardized Response Assessment in Patients with Advanced Cholangiocarcinoma Treated with Personalized Therapy

  2024cites this paper
• Percutaneous microwave ablation for early-stage intrahepatic cholangiocarcinoma: A single-institutional cohort

  2024cites this paper
• New direction: identification of immunoinflammatory subtypes and potential therapeutic targets for cholangiocarcinoma

  2024cites this paper
• The antioxidant, anti-cholangiocarcinoma, and anti-Opisthorchis viverrini activities of ethanolic extract from Antidesma thwaitesianum fruit

  2024cites this paper
• Liver transplantation in the management of cholangiocarcinoma: Evolution and contemporary advances

  2023cites this paper
• ALOX5 acts as a key role in regulating the immune microenvironment in intrahepatic cholangiocarcinoma, recruiting tumor-associated macrophages through PI3K pathway

  2023cites this paper
• Postpartum related intrahepatic cholangiocarcinoma with FGFR2 fusion and severe hyperbilirubinemia with response to FGFR inhibitor pemigatinib: case report and review

  2023cites this paper
• The contribution of new methods in cytology for increasing sensitivity in the diagnosis of extrahepatic bile duct lesions.

  2023cites this paper
• A Systematised Literature Review of Real-World Treatment Patterns and Outcomes in Unresectable Advanced or Metastatic Biliary Tract Cancer

  2023cites this paper
• Prognostic Risk Factors In 113 Patients Undergoing Cephalic Duodenopancreatectomy For Distal Cholangiocarcinoma.

  2023cites this paper
• PLK1 and its substrate MISP facilitate intrahepatic cholangiocarcinoma progression by promoting lymphatic invasion and impairing E-cadherin adherens junctions

  2023cites this paper
• Roles of the PI3K/AKT Signalling Pathway in Cholangiocarcinoma: A Mini Review

  2023cites this paper
• Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker

  2023cites this paper
• A Multicenter Survey on Eligibility for a Randomized Phase III Trial of Adjuvant Chemotherapy for Resected Biliary Tract Cancer (JCOG1202, ASCOT)

  2023cites this paper
• The future direction of liver transplantation for intrahepatic cholangiocarcinoma

  2023cites this paper
• The influence of the extent of lymph node metastasis on the prognosis for patients with intrahepatic cholangiocarcinoma

  2023cites this paper
• The Clinical Significance and Role of CXCL1 Chemokine in Gastrointestinal Cancers

  2023cites this paper
• Prognostic value of integrated morphofunctional imaging methods in inoperable intrahepatic cholangiocarcinoma

  2023cites this paper
• Surgical treatment of the perihilar cholangiocarcinoma with portal vein invasion

  2023cites this paper
• Superior Tumor Detection for 68Ga-FAPI-46 Versus 18F-FDG PET/CT and Conventional CT in Patients with Cholangiocarcinoma

  2023cites this paper
• Clinical Significance of Venous Thromboembolism in Patients with Advanced Cholangiocarcinoma

  2023cites this paper
• Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma

  2023cites this paper
• Ablative Therapy in Non-HCC Liver Malignancy

  2023cites this paper
• Current Role and Future Perspectives of Immunotherapy and Circulating Factors in Treatment of Biliary Tract Cancers

  2023cites this paper
• Mucin 4 Confers Gemcitabine Resistance and an Unfavorable Prognosis in Patients with Cholangiocarcinoma via AKT Activation

  2023cites this paper
• Prognostic Impact of Margin Status in Distal Cholangiocarcinoma

  2023cites this paper
• The novel epithelial-mesenchymal transition-related proteins and their therapeutic targets in cholangiocarcinoma: a narrative review

  2023cites this paper
• Endoscopic reintervention after unilateral metal stent deployment for MHBO using SIS method

  2023cites this paper
• Modified staging system of positive lymph nodes based nomogram in intrahepatic cholangiocarcinoma

  2023cites this paper
• Personalized intrahepatic cholangiocarcinoma prognosis prediction using radiomics: Application and development trend

  2023cites this paper
• The Role of Immunohistochemistry in the Differential Diagnosis between Intrahepatic Cholangiocarcinoma, Hepatocellular Carcinoma and Liver Metastasis, as Well as Its Prognostic Value

  2023cites this paper
• Trans-arterial chemoembolization and radioembolization for treatment of intrahepatic cholangiocarcinoma

  2023cites this paper
• Safety and Efficacy of Hepatic Artery Embolization in Heavily Treated Patients with Intrahepatic Cholangiocarcinoma: Analysis of Clinicopathological and Radiographic Parameters Associated with Better Overall Survival

  2023influential citation
• Survival analysis of extrahepatic cholangiocarcinoma based on surveillance, epidemiology, and end results database

  2023cites this paper
• Comparison of Efficacy and Safety between Endoscopic Retrograde Cholangiopancreatography and Percutaneous Transhepatic Cholangial Drainage for the Treatment of Malignant Obstructive Jaundice: A Systematic Review and Meta-Analysis

  2023cites this paper
• Prognostic Significance of DNA Topoisomerase II Alpha (TOP2A) in Cholangiocarcinoma.

  2023cites this paper
• Any Role for Microbiota in Cholangiocarcinoma? A Comprehensive Review

  2023cites this paper
• Factors affecting outcomes of Yttrium-90 radioembolization in heavily pretreated patients with intrahepatic cholangiocarcinoma

  2023cites this paper
• Liquid biopsy in biliary tract cancer from blood and bile samples: current knowledge and future perspectives

  2022cites this paper
• The Role of Immunosuppression for Recurrent Cholangiocellular Carcinoma after Liver Transplantation

  2022cites this paper
• PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies

  2022cites this paper
• Clinical Impact of Sarcopenia on Cholangiocarcinoma

  2022cites this paper
• Cholangiocarcinoma Attributed to Occupation: A Systematic Reviews

  2022cites this paper